Superpowered Cell Therapies: The Role of Single-Cell Proteomics

Discover recent cutting-edge research in cellular therapy and explore several related case studies.

Your data is secure

We keep your personal information safe and do not share it with any third parties. By submitting this form, you agree to receive communications from IsoPlexis and accept our Privacy Policy. You may unsubscribe at any time.

What's Inside

In this we discuss:

Single-cell functional biomarkers for each stage of the cell therapy development pipeline
CAR-T gets hot under the collar for cancer targets
Single-cell functional proteomic characterization of CAR-NK cells sheds light on improved transduction method
Resolving challenges of oncolytic immunotherapy delivery to disrupt the tumor microenvironment
CAR-T cells: off the shelf and on the mark
A Deeper Look

More about this

Democratizing Single-Cell Proteomics for Optimized Cell Therapy Products and Workflows

Cutting-edge technologies are leading to the development of increasing numbers of novel CAR-T and cell therapies, necessitating the development of more efficient and accurate methods for evaluating the quality of this influx of CAR-T therapy candidates.

IsoPlexis does this on an integrated, walk-away automated platform for single-cell and bulk functional proteomics, providing easy access to highly multiplexed proteomics for virtually any lab.

Download this eBook to explore case studies and learn more!

awards-bar-3-wide-color-right
awards-bar-4-wide-color-left
Get the